title: CrossTalk opposing view: Weighing the evidence for class A GPCR dimers, the jury is still out.
authors.affiliation: Department of Pharmacology and Toxicology, Medical College of Georgia, Georgia Regents University, Augusta, GA, 30912-2300, USA nelambert@gru.edu.
authors.forename: Nevin A
authors.initials: NA
authors.lastname: Lambert
authors.affiliation: Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA.
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Javitch
mesh_terms: D055503:Protein Multimerization; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D043562:Receptors, G-Protein-Coupled